General Information of DTT (ID: TTKLPHO)

DTT Name Neonatal Fc receptor (FCGRT) DTT Info
Gene Name FCGRT

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Efgartigimod alfa DM2M93X Myasthenia gravis 8C6Y Approved [1]
------------------------------------------------------------------------------------
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ARGX-113 DM180DM Myasthenia gravis 8C6Y Phase 3 [2]
Batoclimab DMYPMR8 Myasthenia gravis 8C6Y Phase 3 [3]
Nipocalimab? DM0DYAX Chronic inflammatory demyelinating polyneuropathy 8C01.3 Phase 3 [4]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
SYN-1327 DMFNR75 Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 FDA Approved Drug Products from FDA Official Website. 2021. Application Number: 761195.
2 Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis. Neurology. 2019 Jun 4;92(23):e2661-e2673.
3 Batoclimab as an add-on therapy in neuromyelitis optica spectrum disorder patients with acute attacks. Eur J Neurol. 2023 Jan;30(1):195-203.
4 New Therapies for the Treatment of Warm Autoimmune Hemolytic Anemia. Transfus Med Rev. 2022 Oct;36(4):175-180.
5 Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction. Bioorg Med Chem. 2008 Jun 15;16(12):6394-405.